• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

CINNARIZINE Drug Record

  • Summary
  • Interactions
  • Claims
  • CINNARIZINE chembl:CHEMBL43064 Approved

    Alternate Names:

    516 MD
    R-516
    STUNARONE
    STUGERON FTE
    STUGERON
    R-1575
    MARZINE R.F.
    STUTGIN
    516-MD
    MYLAN TRAVEL SICKNESS
    CINNARIZINE
    1-CINNAMYL-4-(DIPHENYLMETHYL)PIPERAZINE
    1-BENZHYDRYL-4-CINNAMYLPIPERAZIN
    CINNARIZINUM
    STUGERON®
    1-(DIPHENYLMETHYL)-4-(3-PHENYL-2-PROPENYL)PIPERAZINE
    CINARIZINA
    chembl:CHEMBL43064
    drugbank:00568
    chemidplus:298-57-7
    rxcui:2549
    pubchem.compound:1547484

    Drug Info:

    FDA Approval not approved by the FDA
    Drug Class small molecule
    Drug Indications Anti-Allergic Agents
    Year of Approval not approved by the fda
    Drug Class anti-allergic agents
    (1 More Sources)

    Publications:

    Paton et al., Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines)., Clin Pharmacokinet
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    MacDonald ML et al., 2006, Identifying off-target effects and hidden phenotypes of drugs in human cells., Nat Chem Biol
  • CINNARIZINE   CFL1

    Interaction Score: 2.21

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16680159


    Sources:
    DTC

  • CINNARIZINE   JUN

    Interaction Score: 0.4

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16680159


    Sources:
    DTC

  • CINNARIZINE   CDK1

    Interaction Score: 0.37

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16680159


    Sources:
    DTC

  • CINNARIZINE   HRH1

    Interaction Score: 0.35

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name -

    PMIDs:
    2866055 11752352


    Sources:
    TdgClinicalTrial TEND TTD

  • CINNARIZINE   NPSR1

    Interaction Score: 0.11

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • CINNARIZINE   TP53

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16680159


    Sources:
    DTC

  • CINNARIZINE   KCNH2

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: CINNARIZINE

    • Version: 01-August-2011

    Alternate Names:
    CINNARIZINE Primary Drug Name

    Drug Info:
    Drug Class anti-allergic agents
    Year of Approval not approved by the fda

    Publications:

  • TdgClinicalTrial: CINNARIZINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Anti-Allergic Agents
    Drug Class small molecule
    FDA Approval not approved by the FDA

    Publications:

  • DTC: CINNARIZINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL43064 ChEMBL Drug ID

    Drug Info:

    Publications:
    MacDonald ML et al., 2006, Identifying off-target effects and hidden phenotypes of drugs in human cells., Nat Chem Biol

  • TTD: Cinnarizine

    • Version: 2020.06.01

    Alternate Names:
    D0Q3YO TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL43064

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21